Understanding how changes in Medicaid Managed Care affect people with substance use disorders
Examining the Effects of Medicaid Managed Care Organizations' Entries and Exits for Medicaid Enrollees with Substance Use Disorders
This study looks at how changes in Managed Care Organizations affect people on Medicaid who are dealing with substance use disorders, aiming to find out if these changes help or hinder their access to care and the quality of services they receive.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11109736 on NIH RePORTER |
What this research studies
This research investigates how the entry and exit of Managed Care Organizations (MCOs) impact Medicaid enrollees with substance use disorders (SUD). It aims to understand whether these changes improve or disrupt access to care and the quality of services provided. By using a mixed-methods approach, the study will analyze state-level procurement processes and the characteristics of MCOs to identify factors that lead to better outcomes for patients. The goal is to provide insights that can enhance the management of Medicaid services for individuals struggling with SUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults under 21 years old who are enrolled in Medicaid and have substance use disorders.
Not a fit: Patients who are not enrolled in Medicaid or do not have substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to high-quality care for patients with substance use disorders enrolled in Medicaid.
How similar studies have performed: Previous research has shown that changes in managed care can significantly impact access to and quality of behavioral health services, indicating that this approach has potential for meaningful insights.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Lindner, Stephan Reinhard — Oregon Health & Science University
- Study coordinator: Lindner, Stephan Reinhard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.